These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 11981470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation.
    Costas L, Vilella A, Trilla A, Serrano B, Vera I, Roldán M, Sancho MP, Bayas JM, Gascón J, Costa J.
    J Travel Med; 2009; 16(5):344-8. PubMed ID: 19796106
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-benefit analysis of hepatitis a vaccination in Thailand.
    Teppakdee A, Tangwitoon A, Khemasuwan D, Tangdhanakanond K, Suramaethakul N, Sriratanaban J, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
    [Abstract] [Full Text] [Related]

  • 9. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [Abstract] [Full Text] [Related]

  • 10. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Myers RP, Gregor JC, Marotta PJ.
    Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
    [Abstract] [Full Text] [Related]

  • 11. The prevalence and direct costs of pre-immunization testing for hepatitis A in general practice.
    Buckley D, Fahey T, Bevan G.
    Br J Gen Pract; 1996 Sep; 46(410):541-2. PubMed ID: 8917876
    [Abstract] [Full Text] [Related]

  • 12. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E, Shattock AG, Fielding JF.
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A.
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [Abstract] [Full Text] [Related]

  • 15. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
    Al-Aziz AM, Awad MA.
    East Mediterr Health J; 2008 Feb; 14(5):1028-35. PubMed ID: 19161074
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost-utility of universal hepatitis A vaccination in Canada.
    Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.
    Vaccine; 2007 Dec 12; 25(51):8536-48. PubMed ID: 17996339
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M, Munshi SU, Nessa A, Ullah MS, Tabassum S, Islam MN.
    Indian J Med Microbiol; 2009 Dec 12; 27(1):48-50. PubMed ID: 19172060
    [Abstract] [Full Text] [Related]

  • 20. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia.
    Fathalla SE, Al-Jama AA, Al-Sheikh IH, Islam SI.
    Saudi Med J; 2000 Oct 12; 21(10):945-9. PubMed ID: 11369959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.